Invention Grant
- Patent Title: Compounds for treatment of cancer
-
Application No.: US16261353Application Date: 2019-01-29
-
Publication No.: US10660889B2Publication Date: 2020-05-26
- Inventor: Songzhu An
- Applicant: Curegenix, Inc.
- Applicant Address: CN Guangzhou
- Assignee: Curegenix, Inc.
- Current Assignee: Curegenix, Inc.
- Current Assignee Address: CN Guangzhou
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; David Diamond
- Main IPC: A61K31/4985
- IPC: A61K31/4985 ; A61K31/4375 ; A61K31/495 ; A61K31/444 ; A61K31/472 ; A61K31/4725 ; A61K31/496 ; A61K31/501 ; A61K31/506 ; A61K31/5377 ; A61K31/541 ; A61K31/497 ; A61K31/519 ; A61K31/5025
Abstract:
The present invention relates to compounds as inhibitor of WNT signal transduction pathway, as well as a composition comprising the same. Further, the present invention relates to the use of the compounds in the treatment of cancer.
Public/Granted literature
- US20190142827A1 COMPOUNDS FOR TREATMENT OF CANCER Public/Granted day:2019-05-16
Information query
IPC分类:
